Eugene D Kwon

Eugene D Kwon

UNVERIFIED PROFILE

Are you Eugene D Kwon?   Register this Author

Register author
Eugene D Kwon

Eugene D Kwon

Publications by authors named "Eugene D Kwon"

Are you Eugene D Kwon?   Register this Author

100Publications

1621Reads

5Profile Views

Evaluating the Potential Role of Salvage Vesiculectomy for Prostate Cancer Recurrence.

Clin Genitourin Cancer 2019 Jun 6;17(3):e536-e540. Epub 2019 Feb 6.

Department of Urology, Mayo Clinic, Rochester, MN. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.01.019DOI Listing
June 2019

Prostate cancer-specific PET radiotracers: A review on the clinical utility in recurrent disease.

Pract Radiat Oncol 2018 Jan - Feb;8(1):28-39. Epub 2017 Jul 20.

Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2017.07.011DOI Listing
August 2018

Impact of Radical Prostatectomy on Long-Term Oncologic Outcomes in a Matched Cohort of Men with Pathological Node Positive Prostate Cancer Managed by Castration.

J Urol 2017 07 24;198(1):86-91. Epub 2017 Jan 24.

Department of Urology, Mayo Clinic, Rochester, Minnesota; Department of Biostatistics, Mayo Clinic, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2017.01.063DOI Listing
July 2017

Retrospective Review of Percutaneous Image-Guided Ablation of Oligometastatic Prostate Cancer: A Single-Institution Experience.

J Vasc Interv Radiol 2017 Jul 21;28(7):987-992. Epub 2017 Apr 21.

Department of Radiology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2017.03.012DOI Listing
July 2017

Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer.

J Clin Oncol 2017 Jan 31;35(1):40-47. Epub 2016 Oct 31.

Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Eugene D. Kwon, Mayo Clinic, Rochester, MN; Charles G. Drake, Johns Hopkins University, Baltimore, MD; Karim Fizazi, University of Paris-Sud, Villejuif; Gwenaelle Gravis, Institut Paoli-Calmettes, Marseille, France; Christopher Logothetis, University of Texas MD Anderson Cancer Center, Houston, TX; Vinod Ganju, Monash University, Melbourne, Victoria; Siobhan S. Ng, St John of God Hospital, Subiaco, Western Australia; Francis X. Parnis, Adelaide Cancer Centre, Adelaide, South Australia, Australia; Jonathan Polikoff, Southern California Permanente Medical Group, San Marcos, CA; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Piotr Humanski, Niepubliczny Zaklad Opieki Zdrowotnej Specjalista, Kutno, Poland; Josep M. Piulats, Institut Català d'Oncologia, Barcelona; Javier Puente, Hospital Clínico San Carlos, Madrid, Spain; Pablo Gonzalez Mella, Instituto Oncologico, Viña del Mar; Pablo Gonzalez Mella, Fundación Arturo Lopez Pérez, Santiago, Chile; Dirk Jaeger, University Hospital, Heidelberg, Germany; Fabio A. Franke, Hospital de Caridade de Ijuí, Ijuí, Brazil; Roman Carvajal, Hospital Regional Valentin Gomez Farias, Zapopan, Mexico; Lisa Sengeløv, Herlev Hospital, Herlev, Denmark; M. Brent McHenry, Bristol-Myers Squibb, Wallingford, CT; Arvind Varma, DOCS Inc, New York, NY; Alfonsus J. van den Eertwegh, VU University Medical Center, Amsterdam; and Winald Gerritsen, Radboud University, Nijmegen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.1584DOI Listing
January 2017

Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer.

Int J Radiat Oncol Biol Phys 2016 06 29;95(2):696-702. Epub 2016 Jan 29.

Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.01.032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154616PMC
June 2016

Prostate cancer post-treatment follow-up and recurrence evaluation.

Abdom Radiol (NY) 2016 05;41(5):862-76

Department of Radiology, Mayo Clinic, 200 First St. SW, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00261-015-0562-1
Publisher Site
http://dx.doi.org/10.1007/s00261-015-0562-1DOI Listing
May 2016

Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma.

Clin Cancer Res 2015 Sep 21;21(18):4224-33. Epub 2015 May 21.

Human Cellular Therapy Laboratory, Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0260DOI Listing
September 2015

PD-1 Restrains Radiotherapy-Induced Abscopal Effect.

Cancer Immunol Res 2015 Jun 19;3(6):610-9. Epub 2015 Feb 19.

Department of Immunology, Mayo Clinic, Rochester, Minnesota. Department of Urology, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-14-0138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827718PMC
June 2015

Immunotherapy in prostate cancer.

Curr Urol Rep 2015 Jun;16(6):34

Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11934-015-0509-7DOI Listing
June 2015

Immune monitoring using the predictive power of immune profiles.

J Immunother Cancer 2013 27;1. Epub 2013 Jun 27.

Human Cellular Therapy Laboratory, Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2051-1426-1-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266565PMC
December 2014

B7-H1 signaling is integrated during CD8(+) T cell priming and restrains effector differentiation.

Cancer Immunol Immunother 2014 Aug 4;63(8):859-67. Epub 2014 Jun 4.

Biology Discipline, University of Minnesota, Morris, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-014-1563-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833388PMC
August 2014

B7-H1 expression in malignant pleural mesothelioma is associated with sarcomatoid histology and poor prognosis.

J Thorac Oncol 2014 Jul;9(7):1036-40

*Division of Medical Oncology; †Department of Laboratory Medicine and Pathology; ‡Division of Pulmonary and Critical Care Medicine; §Department of Urology; and ¶Department of Immunology, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153033
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058651PMC
July 2014

Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up.

BJU Int 2013 Jun 2;111(7):1046-53. Epub 2013 Apr 2.

Department of Internal Medicine, Mayo Clinic and Mayo Medical School, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12075DOI Listing
June 2013

Tumor B7-H1 and B7-H3 expression in squamous cell carcinoma of the lung.

Clin Lung Cancer 2013 Mar 4;14(2):157-63. Epub 2012 Aug 4.

Department of Laboratory Medicine and Pathology, Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S152573041200131
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2012.05.006DOI Listing
March 2013

Potential role of genetic markers in the management of kidney cancer.

Eur Urol 2013 Feb 24;63(2):333-40. Epub 2012 Sep 24.

Clinic of Urology and Pediatric Urology, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2012.09.040DOI Listing
February 2013

Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer.

Front Oncol 2012 22;2:215. Epub 2013 Jan 22.

Department of Radiation Oncology, Moffitt Cancer Center Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2012.00215DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551203PMC
January 2013

B7-H1 limits the entry of effector CD8(+) T cells to the memory pool by upregulating Bim.

Oncoimmunology 2012 Oct;1(7):1061-1073

Department of Immunology; College of Medicine; Mayo Clinic; Rochester, MN USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.20850DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494620PMC
October 2012

B7-h1 expressed by activated CD8 T cells is essential for their survival.

J Immunol 2011 Dec 24;187(11):5606-14. Epub 2011 Oct 24.

Department of Immunology, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1003976DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221917PMC
December 2011

Programmed death 1 is expressed in cutaneous infiltrates of mycosis fungoides and Sézary syndrome.

Am J Hematol 2011 Mar 15;86(3):325-7. Epub 2011 Feb 15.

Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21960DOI Listing
March 2011

B7-H1 expression in vestibular schwannomas.

Otol Neurotol 2010 Aug;31(6):991-7

Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic School of Medicine, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAO.0b013e3181e40e4fDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810681PMC
August 2010

Tissue microarrays: one size does not fit all.

Diagn Pathol 2010 Jul 7;5:48. Epub 2010 Jul 7.

Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1746-1596-5-48DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910003PMC
July 2010

T-cell co-regulatory molecule expression in renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.

Urology 2009 Dec 7;74(6):1359-64. Epub 2009 Jun 7.

Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2009.03.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789880PMC
December 2009

Inhibitors of B7-CD28 costimulation in urologic malignancies.

Immunotherapy 2009 Jan;1(1):129-39

Memorial Sloan-Kettering Cancer Center, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/1750743X.1.1.129DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864044PMC
January 2009

Hormone receptor expression in renal angiomyolipoma: clinicopathologic correlation.

Urology 2008 Oct 28;72(4):927-32. Epub 2008 Mar 28.

Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2008.01.067DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789392PMC
October 2008

Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage.

Cancer Res 2008 Aug;68(15):6054-8

Department of Surgery, Urology Service, Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-0869DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2918370PMC
August 2008

Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas.

Cancer 2008 Jun;112(12):2676-82

Department of Pathology, University of Massachusetts Medical Center, Worcester, Massachusetts 01605, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23484DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789394PMC
June 2008

B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence.

J Urol 2008 May 20;179(5):1954-9; discussion 1959-60. Epub 2008 Mar 20.

Department of Urology, Mayo Graduate School of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2008.01.056DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789396PMC
May 2008

Costimulation, coinhibition and cancer.

Curr Cancer Drug Targets 2007 Feb;7(1):15-30

Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
February 2007

Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy.

Clin Cancer Res 2007 Jan;13(2 Pt 2):709s-715s

Departments of Urology and Immunology, Mayo Medical School, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-1868DOI Listing
January 2007

Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancer.

Urol Oncol 2006 Sep-Oct;24(5):442-7

Department of Urology, Mayo Clinic and Mayo Medical School, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2005.08.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976273PMC
December 2006

Significance of B7-H1 overexpression in kidney cancer.

Clin Genitourin Cancer 2006 Dec;5(3):206-11

Departments of Urology and Immunology, Mayo Medical School, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CGC.2006.n.038DOI Listing
December 2006

Extranodal extension in regional lymph nodes is associated with outcome in patients with renal cell carcinoma.

J Urol 2006 Nov;176(5):1978-82; discussion 1982-3

MUSC Pathology Associates, Oconee Memorial Hospital, Seneca, South Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2006.07.026DOI Listing
November 2006

The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.

J Urol 2006 Nov;176(5):1990-5; discussion 1995

Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2006.07.015DOI Listing
November 2006

Second primary malignancies associated with renal cell carcinoma histological subtypes.

J Urol 2006 Sep;176(3):900-3; discussion 903-4

Department of Urology, Mayo Medical School and Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2006.04.080DOI Listing
September 2006

Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomy.

Urology 2006 Sep 18;68(3):604-8. Epub 2006 Sep 18.

Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2006.03.041DOI Listing
September 2006

Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy.

Cancer 2006 Aug;107(4):712-20

Department of Urology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.22060
Publisher Site
http://dx.doi.org/10.1002/cncr.22060DOI Listing
August 2006

Immunotherapy for prostate cancer.

Curr Pharm Des 2006 ;12(7):807-17

Southern Illinois University School of Medicine, Division of Urology, Sprngfield 62794, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138161206776056001DOI Listing
March 2006

Prostate cancer immunology: biology, therapeutics, and challenges.

J Clin Oncol 2005 Nov;23(32):8262-9

Department of Urology, Mayo Clinic and Mayo Medical School, 200 1st St SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.03.4595DOI Listing
November 2005

Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma?

J Urol 2005 Oct;174(4 Pt 1):1218-21

Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ju.0000173942.19990.40DOI Listing
October 2005

Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.

Cancer 2005 Aug;104(3):511-20

Department of Urology, Mayo Medical School and Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21206DOI Listing
August 2005

Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy.

Cancer 2005 Jul;104(1):53-60

Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21125DOI Listing
July 2005